Home
>
National Drug Code (NDC)
>
Integrilin
Integrilin - 0085-1177-02 - (Eptifibatide)
Drug Information of Integrilin
| Product NDC: | 0085-1177 |
| Proprietary Name: | Integrilin |
| Non Proprietary Name: | Eptifibatide |
| Active Ingredient(s): | 2 mg/mL & nbsp; Eptifibatide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Integrilin
| Product NDC: | 0085-1177 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020718 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980518 |
Package Information of Integrilin
| Package NDC: | 0085-1177-02 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0085-1177-02) > 100 mL in 1 VIAL, SINGLE-USE |
NDC Information of Integrilin
| NDC Code | 0085-1177-02 |
| Proprietary Name | Integrilin |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0085-1177-02) > 100 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0085-1177 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Eptifibatide |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19980518 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | EPTIFIBATIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
